AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14614633 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 43
Study 11026626 — intervention group
Group type: EXPERIMENTAL
Intervention: Deuterium incorporation (DI) method
Number of subjects: 14
Study 11026626 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma cholesterol precursor levels
Number of subjects: 14
Study 9503879 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed-effect two-state model with multiplicative bivariate log-normal random effects
Number of subjects: 0
Study 9503879 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum likelihood estimation using Gauss-Hermite integration and Newton-Raphson procedure
Number of subjects: 0
Study 9503879 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of methodology to data from a multi-center clinical trial
Number of subjects: 0
Study 8368986 — intervention group
Group type: EXPERIMENTAL
Intervention: Benadryl (diphenhydramine) 50 mg
Number of subjects: 28
Study 8368986 — intervention group
Group type: EXPERIMENTAL
Intervention: Hismanal (astemizole) 10 mg
Number of subjects: 28
Study 8368986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 3530647 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure (PEEP) at 10 cm H2O with FIO2 = 0.6
Number of subjects: 44
Study 3530647 — intervention group
Group type: COMPARATOR
Intervention: Positive end-expiratory pressure (PEEP) at 0, 5, or 10 cm H2O
Number of subjects: 44
Study 3530647 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative P(A‐a)O2 measurements
Number of subjects: 44
Study 3530647 — intervention group
Group type: EXPERIMENTAL
Intervention: Roentgenographic evidence of atelectasis
Number of subjects: 44
Study 3530647 — intervention group
Group type: EXPERIMENTAL
Intervention: Roentgenographic distances from hemidiaphragm to lung apex
Number of subjects: 44
Study 30241517 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 days of amoxicillin dispersible tablets (DT) followed by 2 days of placebo DT
Number of subjects: 2000
Study 30241517 — intervention group
Group type: COMPARATOR
Intervention: 5 days of amoxicillin dispersible tablets (DT)
Number of subjects: 2000
Study 26603771 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone injection
Number of subjects: 94
Study 26603771 — intervention group
Group type: COMPARATOR
Intervention: Pulpotomy
Number of subjects: 94
Study 24202666 — intervention group
Group type: EXPERIMENTAL
Intervention: wDP (docetaxel 35 mg/m² + cisplatin 60 mg/m²)
Number of subjects: 77
Study 24202666 — intervention group
Group type: EXPERIMENTAL
Intervention: wDO (docetaxel 35 mg/m² + oxaliplatin 120 mg/m²)
Number of subjects: 77
Study 24202666 — intervention group
Group type: EXPERIMENTAL
Intervention: wDP
Number of subjects: 77
Study 24202666 — intervention group
Group type: EXPERIMENTAL
Intervention: wDO
Number of subjects: 77
Study 23710844 — intervention group
Group type: EXPERIMENTAL
Intervention: email health information prescriptions (eHIP)
Number of subjects: 592
Study 23710844 — intervention group
Group type: COMPARATOR
Intervention: paper health information prescriptions (pHIP)
Number of subjects: 592
Study 20482513 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 0
Study 20482513 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 0
Study 20482513 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 0
Study 20482513 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiapride
Number of subjects: 0
Study 20482513 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0
Study 20482513 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0
Study 20482513 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 0
Study 18500605 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural ropivacaine alone
Number of subjects: 201
Study 18500605 — intervention group
Group type: EXPERIMENTAL
Intervention: IV remifentanil alone
Number of subjects: 201
Study 18500605 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural ropivacaine plus IV remifentanil
Number of subjects: 201
Study 18500605 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural ropivacaine plus IV acetaminophen
Number of subjects: 201
Study 18500605 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia (ropivacaine)
Number of subjects: 201
Study 18500605 — intervention group
Group type: COMPARATOR
Intervention: IV remifentanil
Number of subjects: 201
Study 15820798 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH antagonist (minimal stimulation protocol)
Number of subjects: 70
Study 15820798 — intervention group
Group type: COMPARATOR
Intervention: Natural-cycle IVF (control)
Number of subjects: 70
Study 12024842 — intervention group
Group type: EXPERIMENTAL
Intervention: Li vasectomy
Number of subjects: 99
Study 12024842 — intervention group
Group type: COMPARATOR
Intervention: Standard vasectomy with bilateral incision
Number of subjects: 99
Study 12024842 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 99
Study 10527011 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 490
Study 10527011 — intervention group
Group type: COMPARATOR
Intervention: No ICD therapy (Control)
Number of subjects: 490
Study 7851588 — intervention group
Group type: EXPERIMENTAL
Intervention: hMG
Number of subjects: 0
Study 7851588 — intervention group
Group type: EXPERIMENTAL
Intervention: leuprolide acetate (LA) plus hMG
Number of subjects: 0
Study 7851588 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 1951102 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous diltiazem
Number of subjects: 18
Study 1951102 — intervention group
Group type: COMPARATOR
Intervention: Intravenous nitroglycerin
Number of subjects: 18
Study 6780105 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive rehabilitation
Number of subjects: 121
Study 6780105 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional rehabilitation
Number of subjects: 121
Study 6780105 — intervention group
Group type: COMPARATOR
Intervention: No routine rehabilitation
Number of subjects: 121
Study 31665927 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of diabetes distress (DD)
Number of subjects: 166
Study 31665927 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher levels of depressive symptoms (DS)
Number of subjects: 166
Study 31665927 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender (female)
Number of subjects: 166
Study 31665927 — intervention group
Group type: COMPARATOR
Intervention: Gender
Number of subjects: 166
Study 30165127 — intervention group
Group type: COMPARATOR
Intervention: Intensity Modulated Radiation Therapy (IMRT)
Number of subjects: 212
Study 30165127 — intervention group
Group type: COMPARATOR
Intervention: Passive Scattering Proton Therapy (PSPT)
Number of subjects: 212
Study 30165127 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive Planning
Number of subjects: 212
Study 30165127 — intervention group
Group type: EXPERIMENTAL
Intervention: Large tumors
Number of subjects: 212
Study 30165127 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive Planning for Large Tumors
Number of subjects: 212
Study 28049736 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (4 months treatment)
Number of subjects: 39
Study 28049736 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 39
Study 28049736 — intervention group
Group type: COMPARATOR
Intervention: Calorie restriction (control)
Number of subjects: 39
Study 25856169 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose caffeine (80 mg/kg i.v.)
Number of subjects: 74
Study 25856169 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose caffeine (20 mg/kg i.v.)
Number of subjects: 74
Study 23674932 — intervention group
Group type: COMPARATOR
Intervention: Intensive Lifestyle Intervention (ILI) - 1-year program (n = 59)
Number of subjects: 133
Study 23674932 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y Gastric Bypass (RYGB) - (n = 74)
Number of subjects: 133
Study 23120958 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health education at Kenyatta National Hospital (KNH)
Number of subjects: 195
Study 23120958 — intervention group
Group type: COMPARATOR
Intervention: Non-intervention group at Mbagathi district hospital (MDH)
Number of subjects: 195
Study 18948162 — intervention group
Group type: EXPERIMENTAL
Intervention: quetiapine XR 300 mg once daily
Number of subjects: 0
Study 18948162 — intervention group
Group type: COMPARATOR
Intervention: quetiapine IR 150 mg twice daily
Number of subjects: 0
Study 18948162 — intervention group
Group type: EXPERIMENTAL
Intervention: quetiapine XR 300 mg once daily and quetiapine IR 150 mg twice daily
Number of subjects: 0
Study 17990061 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine nasal spray (1 mg or 2 mg)
Number of subjects: 60
Study 17990061 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 60
Study 17990061 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine nasal spray (1 mg or 2 mg) with motion stimulation
Number of subjects: 60
Study 14512795 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel monotherapy (100 mg/m2 intravenously on day 1 each week for 6 weeks)
Number of subjects: 40
Study 14512795 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel and carboplatin combination (Paclitaxel 80 mg/m2 intravenously followed by carboplatin 200 mg/m2 on day 1 each week for 6 weeks)
Number of subjects: 40
Study 11216145 — intervention group
Group type: EXPERIMENTAL
Intervention: Premature delivered twins
Number of subjects: 20
Study 11216145 — intervention group
Group type: EXPERIMENTAL
Intervention: Premature delivered twins (born 48 hours after first twin)
Number of subjects: 20
Study 11216145 — intervention group
Group type: COMPARATOR
Intervention: Term delivered twins
Number of subjects: 20
Study 8846860 — intervention group
Group type: EXPERIMENTAL
Intervention: Loco-regional radiotherapy to the breast
Number of subjects: 418
Study 8846860 — intervention group
Group type: COMPARATOR
Intervention: No loco-regional radiotherapy to the breast
Number of subjects: 418
Study 8846860 — intervention group
Group type: EXPERIMENTAL
Intervention: Incomplete local excision with radiotherapy
Number of subjects: 418
Study 1445814 — intervention group
Group type: EXPERIMENTAL
Intervention: High humidity (80-93% relative humidity) at 20 and 30 degrees
Number of subjects: 8
Study 1445814 — intervention group
Group type: COMPARATOR
Intervention: Ambient humidity (50-65% relative humidity) at 20 and 30 degrees
Number of subjects: 8
Study 1445814 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature at ambient humidity levels (20, 23, 26, and 30 degrees)
Number of subjects: 8
Study 1445814 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeping metabolic rate and energy cost of walking and cycling
Number of subjects: 8
Study 3846592 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalosporins
Number of subjects: 78
Study 3846592 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalosporins (specific types)
Number of subjects: 78
Study 3846592 — intervention group
Group type: EXPERIMENTAL
Intervention: Latamoxef (moxalactam)
Number of subjects: 78
Study 3846592 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotetan
Number of subjects: 78
Study 3846592 — intervention group
Group type: COMPARATOR
Intervention: Penicillins
Number of subjects: 78
Study 3846592 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study 29135601 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise at 30% maximal voluntary contraction
Number of subjects: 40
Study 29135601 — intervention group
Group type: COMPARATOR
Intervention: Sham isometric handgrip exercise at 3% maximal voluntary contraction
Number of subjects: 40
Study 26304156 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-topotecan followed by carboplatin-paclitaxel (Arm 1)
Number of subjects: 0
Study 26304156 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin-paclitaxel (Arm 2)
Number of subjects: 0
Study 25417416 — intervention group
Group type: EXPERIMENTAL
Intervention: Warming needle moxibustion
Number of subjects: 37
Study 22748043 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin/vinorelbine (ACT)
Number of subjects: 596
Study 22748043 — intervention group
Group type: COMPARATOR
Intervention: Observation alone (Control)
Number of subjects: 596
Study 20202055 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional MMR vaccine
Number of subjects: 135
Study 20202055 — intervention group
Group type: COMPARATOR
Intervention: Intralesional saline (control)
Number of subjects: 135
Study 17118570 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy (50.4 Gy, 5-fluorouracil, leucovorin) with delayed surgery
Number of subjects: 291
Study 17118570 — intervention group
Group type: COMPARATOR
Intervention: 5 x 5 Gy preoperative radiotherapy with immediate surgery
Number of subjects: 291
Study 16287372 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate group (C)
Number of subjects: 30
Study 16287372 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (P)
Number of subjects: 30
Study 11969282 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative education by multidisciplinary team prior to admission for surgery.
Number of subjects: 356
Study 11969282 — intervention group
Group type: COMPARATOR
Intervention: Usual care education on admission and throughout hospital stay.
Number of subjects: 356
Study 10333652 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile discrimination of the right hand (left hemisphere)
Number of subjects: 13
Study 10333652 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactile discrimination of the left hand (right hemisphere)
Number of subjects: 13
Study 8950804 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA‐A, ‐B, ‐DR and DQ phenotypes
Number of subjects: 217
Study 8950804 — intervention group
Group type: COMPARATOR
Intervention: Comparison with Caucasoids, Negroids and Orientals
Number of subjects: 217
Study 8950804 — intervention group
Group type: EXPERIMENTAL
Intervention: Linkage disequilibrium analysis
Number of subjects: 217
Study 2249011 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy and radiotherapy (C + R group)
Number of subjects: 151
Study 2249011 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (R group)
Number of subjects: 151
Study 6990761 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ritodrine
Number of subjects: 70
Study 6990761 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 70
Study 31004732 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate mountain hiking and balneotherapy
Number of subjects: 139
Study 31004732 — intervention group
Group type: COMPARATOR
Intervention: Cultural holiday with sightseeing
Number of subjects: 139
Study 27271517 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapeutic treatment recommendation implemented
Number of subjects: 306
Study 27271517 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient psychotherapy recommendation implemented
Number of subjects: 306
Study 25908395 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard letter signed by general practitioner inviting patients to take a fecal occult blood test.
Number of subjects: 3422
Study 25908395 — intervention group
Group type: COMPARATOR
Intervention: Standard invitation letter or standard reminder letter (Control group).
Number of subjects: 3422
Study 24620913 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtered Back Projection (FBP) at 75% exposure
Number of subjects: 18
Study 24620913 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinogram-affirmed iterative reconstruction at 75% exposure
Number of subjects: 18
Study 24620913 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinogram-affirmed iterative reconstruction at 100% exposure
Number of subjects: 18
Study 24620913 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinogram-affirmed iterative reconstruction at 25% and 50% exposure reduction
Number of subjects: 18
Study 24620913 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinogram-affirmed iterative reconstruction for 10 mm lesions
Number of subjects: 18
Study 24620913 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinogram-affirmed iterative reconstruction for 15 mm lesions
Number of subjects: 18
Study 22050623 — intervention group
Group type: EXPERIMENTAL
Intervention: Nictitating membrane removal (n = 4)
Number of subjects: 8
Study 22050623 — intervention group
Group type: COMPARATOR
Intervention: Nictitating membrane intact (n = 4)
Number of subjects: 8
Study 20027411 — intervention group
Group type: EXPERIMENTAL
Intervention: Zyoptix LASIK (Bausch & Lomb)
Number of subjects: 37
Study 20027411 — intervention group
Group type: COMPARATOR
Intervention: Planoscan LASIK (Bausch & Lomb)
Number of subjects: 37
Study 17937798 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental practice embedded in daily therapy
Number of subjects: 0
Study 17937798 — intervention group
Group type: COMPARATOR
Intervention: Therapy as usual
Number of subjects: 0
Study 15359375 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 68
Study 15359375 — intervention group
Group type: COMPARATOR
Intervention: Reboxetine
Number of subjects: 68
Study 11427271 — intervention group
Group type: EXPERIMENTAL
Intervention: QS-21 in phosphate-buffered saline at pH 6.0 or 7.2
Number of subjects: 63
Study 11427271 — intervention group
Group type: COMPARATOR
Intervention: Phosphate-buffered saline (PBS)
Number of subjects: 63
Study 11427271 — intervention group
Group type: EXPERIMENTAL
Intervention: QS-21/PBS
Number of subjects: 63
Study 11427271 — intervention group
Group type: EXPERIMENTAL
Intervention: QS-21/aluminum hydroxide
Number of subjects: 63
Study 11427271 — intervention group
Group type: EXPERIMENTAL
Intervention: QS-21/4 mg/ml of polysorbate 80
Number of subjects: 63
Study 11427271 — intervention group
Group type: COMPARATOR
Intervention: Aluminum hydroxide (without QS-21)
Number of subjects: 63
Study 11427271 — intervention group
Group type: EXPERIMENTAL
Intervention: QS-21/0.72% benzyl alcohol
Number of subjects: 63
Study 11427271 — intervention group
Group type: EXPERIMENTAL
Intervention: QS-21/30 mg/ml of hydroxypropyl-beta-cyclodextrin
Number of subjects: 63
Study 11427271 — intervention group
Group type: EXPERIMENTAL
Intervention: QS-21/8-mg/ml of polysorbate 80
Number of subjects: 63
Study 9507412 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve conduction velocity distribution (CVD) study of motor nerves (external popliteal and ulnar nerves bilaterally)
Number of subjects: 138
Study 9507412 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve conduction velocity distribution (CVD) study of sensory nerves (median nerve bilaterally)
Number of subjects: 138
Study 9507412 — intervention group
Group type: COMPARATOR
Intervention: Standard electrophysiological examination of motor nerves
Number of subjects: 138
Study 9507412 — intervention group
Group type: COMPARATOR
Intervention: Standard electrophysiological examination of sensory nerves
Number of subjects: 138
Study 9507412 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD study compared to standard examination
Number of subjects: 138
Study 9507412 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD study for patients with motor and mixed subclinical neuropathy
Number of subjects: 138
Study 9507412 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD study findings unaccompanied by slowing of maximum nerve conduction velocity
Number of subjects: 138
Study 9507412 — intervention group
Group type: EXPERIMENTAL
Intervention: CVD study findings for sensory nerves
Number of subjects: 138
Study 8296279 — intervention group
Group type: EXPERIMENTAL
Intervention: Exosurf
Number of subjects: 48
Study 8296279 — intervention group
Group type: EXPERIMENTAL
Intervention: Curosurf
Number of subjects: 48
Study 1523282 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 35
Study 1523282 — intervention group
Group type: EXPERIMENTAL
Intervention: Clovoxamine
Number of subjects: 35
Study 1523282 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 347870 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel
Number of subjects: 74
Study 347870 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo gel
Number of subjects: 74
Study 347870 — intervention group
Group type: EXPERIMENTAL
Intervention: Steradent
Number of subjects: 74
Study 347870 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo solution
Number of subjects: 74
Study 31678069 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingestion of 170g pork loin (36g protein, 5g fat)
Number of subjects: 30
Study 31113205 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led structured education program
Number of subjects: 96
Study 31113205 — intervention group
Group type: COMPARATOR
Intervention: Control group (managed as per clinical guidelines without structured education)
Number of subjects: 96
Study 28103850 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 120
Study 28103850 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 120
Study 26016866 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (GFJ) 340 mL/d providing 210 mg naringenin glycosides
Number of subjects: 48
Study 26016866 — intervention group
Group type: COMPARATOR
Intervention: Matched control drink without flavanones
Number of subjects: 48
Study 26016866 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (GFJ)
Number of subjects: 48
Study 23490394 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic treatment (DT) for 24‐72 weeks based on viral decline rates
Number of subjects: 103
Study 23490394 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) for 24, 48 or 72 weeks
Number of subjects: 103
Study 23490394 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic treatment (DT)
Number of subjects: 103
Study 23490394 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 103
Study 23490394 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic treatment (DT) among patients who achieved undetectable HCV RNA
Number of subjects: 103
Study 23490394 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) among patients who achieved undetectable HCV RNA
Number of subjects: 103
Study 21733046 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive of 1 month of free treatment every fourth month of regularly respected visits (Group 2)
Number of subjects: 221